Stem cell clones could yield new drug treatment for deadly blood disease

Read more

A Question of Trust

Read more

Global Type I diabetes treatment market value doubling to $13.6 billion by 2023: GlobalData

Read more

Targeted therapies offer novel treatment modalities for breast cancer: Frost & Sullivan

Read more

Reorienting the innovation management process

Read more

In Your Genes

Read more

US FDA, DCG(I) explore more ways to work together

Read more

SC stays Delhi HC order against Glenmark

Read more

End of Wockhardt’s Chikalthana USFDA woes?

Read more

Sun Pharma closes merger deal with Ranbaxy

Read more